Biomedicine and pharmacotherapy

ISSN: 0753-3322

Périodicité: 10 n° par an

Format: 210x280

1ère publication: 1956

Langue de publication: A

Marque / éditeur: ELSEVIER

Indexation: Biosis/Biological Abstracts , Current Contents/Life Sciences , Embase/Excerpta Medica , Medline/Index Medicus , Pascal/Inist-CNRS , Science Citation Index , SciSearch, Scopus

Copyright : Elsevier Masson SAS

Biomedicine and pharmacotherapy

Haim Tapiero (Rédacteur en chef), D. Machover (Rédacteur en chef), K.D. Tew (Rédacteur en chef)

An international multidisciplinary journal with two objectives :- to create an interface between clinical and laboratory responses to drugs and to investigate critical approaches to different pathologies with regard to biological and clinical data,- to provide a niche for authors whose work is not directly defined by the review criteria of existing journals. Biomedicine and pharmacotherapy is one of the few journals at the forefront of fundamental and technical science, biological and medical disciplines, therapeutics and pathological description. General fields of interest include molecular and cell biology, genetic disease, immunology and immunoregulation and chemotherapy. Special emphasis is placed on studies of specific topics such as differentiation, pharmacology and toxicology, preclinical and clinical pharmacology, the effects of drugs on cell structural and functional elements, the mechanism of gene regulation in normal and pathological cells, the role of viruses and parasites and the therapy of the diseases they induce. Brief reports of meetings, symposia and conferences will also be considered for publication as well as announcements of scientific meetings or academic courses.

Lire la suite Masquer

Articles en prépublication
- - Corrigendum to “SDH, a novel diarylheptane compound, is a potential treatment for inflammatory bowel disease by restoring epithelial barrier function” [Biomed. Pharmacother. 151 (2022) 113080]
  - Fei Yang, Xiaoqiang Zhu, Liu Li, Yanping Wang, Qing Xie, Yu Cao, Yunhui Yu, Minjie Zhang, Dong Li, Ling Li, Zhongtian Liu, Biyan Zhang, Zijun Chen, Shiping Deng, Yunsen Li
  - Disponible en ligne depuis le vendredi 3 avril 2026
- - Corrigendum “Development and optimization of paclitaxel-loaded Eudragit/PLGA nanoparticles by simplex lattice mixture design: Exploration of improved hemocompatibility and in vivo kinetics” [Biomed. Pharmacother. 144 (2021) 112286]
  - Gunjan Jeswani, Lipika Chablani, Umesh Gupta, Rakesh K. Sahoo, Kartik T. Nakhate
  - Disponible en ligne depuis le jeudi 2 avril 2026
- - Retraction notice to "Multiple strategies with the synergistic approach for addressing colorectal cancer" [Biomedicine & Pharmacotherapy 140 (2021) 111704]
  - Chenmala Karthika, Balaji Hari, Md. Habibur Rahman, Rokeya Akter, Agnieszka Najda, Ghadeer M. Albadrani, Amany A. Sayed, Muhammad Furqan Akhtar, Mohamed M. Abdel-Daim
  - Disponible en ligne depuis le jeudi 2 avril 2026
- - Corrigendum to “Lipid-based nanocarriers co-loaded with artemether and triglycerides of docosahexaenoic acid: Effects on human breast cancer cells” [Biomed. Pharmacother. 134 (2021) 111114]
  - Elisa Gomes Lanna, Raoni Pais Siqueira, Marina Guimarães Carvalho Machado, Aline de Souza, Izabel Cristina Trindade, Renata Tupinambá Branquinho, Vanessa Carla Furtado Mosqueira
  - Disponible en ligne depuis le mercredi 1 avril 2026
- - Corrigendum to “A fully human monoclonal antibody targeting Semaphorin 5A alleviates the progression of rheumatoid arthritis” [Biomed. Pharmacother. 168 (2023) 115666]
  - Yang Qin, Jiayi Jin, Jiani Zhang, Hui Wang, Li Liu, Yanwen Zhang, Sunwang Ling, Jinzhu Hu, Nuan Li, Jianguang Wang, Chen Lv, Xinyu Yang
  - Disponible en ligne depuis le mardi 31 mars 2026
- - Voir +

Contenu(s) associé(s)

- La revue n'est plus publiée par Elsevier Masson. Pour avoir les données les plus à jour, visitez le site général du groupe Elsevier www.elsevier.com.

Articles gratuits
- - MG-101, a cysteine protease inhibitor identified through high-throughput screening, exhibits in vivo efficacy and synergy with remdesivir against SARS-CoV-2
  - Jinyeong Heo, Soonju Park, Honggun Lee, Yeonguk Jeon, Sangeun Jeon, Dawoon Lee, Inhee Choi, Young Mi Kim, Ju Hwan Jeong, Seong Cheol Min, Min-Suk Song, Seungtaek Kim, David Shum, Jiho Kim
  - Vol 196 - Article 119076
- - Megakaryocytes and afucosylated IgG in post-acute COVID-19: Bridging immune dysregulation and vascular pathology — A narrative review
  - Salma Labied, Farah Atifi, Hicham Wahnou, Meryem Mabrouk, Othmane Jeddoub, Afaf Allaoui, Farid Jalali, Younes Zaid
  - Vol 196 - Article 119049
- - Exosome-mediated antiviral testing system and identification of Punicalagins and Anthocyanidins as promising antiviral agents against SARS-CoV-2
  - Raghuram Kandimalla, Farrukh Aqil, Divyasha Saxena, Margaret Wallen, Mohd Saeed, Disha N. Moholkar, Jeyaprakash Jeyabalan, Wendy Spencer, Charles D. Anderson, Jon D. Gabbard, William E. Severson, Kenneth E. Palmer, Ramesh Gupta
  - Vol 196 - Article 119111
- - Integrated systems vaccinology reveals distinct metabolic responses to SARS-CoV-2 infection and DNA-based vaccines in ferrets
  - Gustaf Ahlén, Anoop Ambikan, Flora Mikaeloff, Sefanit Rezene, Jingyi Yan, Negin Nikouyan, Chandrashekar Bangalore Revanna, Sofia Appelberg, Ali Mirazimi, Matti Sällberg, Ujjwal Neogi, Soham Gupta
  - Vol 193 - Article 118858
- - Bridging predictions with experimental reality: In vitro evaluation of phenolic natural products as SARS-CoV-2 exoribonuclease inhibitors
  - Matěj Danda, Barbora Chvátalová, Daniela Nečasová, Ivana Křížová, Tomáš Ruml, Michaela Rumlová
  - Vol 192 - Article 118588
- - Aloe-derived polysaccharides (APS) mitigate SARS-CoV-2 Omicron BQ1.1 infection by preserving epithelial integrity and reducing viral load in human airway epithelial (HAE) cultures
  - Wilfried Posch, Ekambaranellore Prakash, Sophie Ann Erckert, Viktoria Zaderer, Rosa Bellmann-Weiler, Uvarani Chokkalingam, Singh Anuma, Stefan Pöhlmann, Markus Hoffmann, Doris Wilflingseder
  - Vol 192 - Article 118657
- - Non-clinical GLP genotoxicity and rodent oral toxicity studies of 6′-hydroxy justicidin B for anti-COVID-19 agent development
  - Min Heui Yoo, Seng-Min Back, Min Seong Jang, Junguk Choi, Jihyun Jeon, Kyong-Cheol Ko, Yong-Bum Kim
  - Vol 192 - Article 118708
- - Hydroxypropyl-Beta-Cyclodextrin (HP-BCD) inhibits SARS-CoV-2 replication by modulating intracellular lipid dynamics and preventing viral replication complex formation
  - Bruno Braz Bezerra, Keylla Vitória Gomes Macedo, Isadora Alonso Correa, Sharton Vinicius Antunes Coelho, Marcos Romario Matos de Souza, Barbara Martins Cordeiro, Carlos Frederico Leite Fontes, Fabiana Avila Carneiro, Flavio Matassoli, Luciana Jesus Costa, James E.K. Hildreth, Luciana Barros Arruda
  - Vol 191 - Article 118465
- - Image based subcellular mapping of the protein landscape of SARS-CoV-2 infected cells for target-centric drug repurposing
  - Marianna Tampere, Trang H. Le, Elin Asp, Adelinn Kalman, Jayasankar Mohanakrishnan Kaimal, Duncan Njenda, Anna Bäckström, Ulrika Axelsson, Hao Xu, Wei Ouyang, Hanna Axelsson, Francesco Marabita, Elisabeth Moussaud-Lamodière, Carolina Oses Sepulveda, Brinton Seashore-Ludlow, Caroline Vernersson, Ali Mirazimi, Emma Lundberg, Päivi Östling, Charlotte Stadler
  - Vol 191 - Article 118447
- - Identification of nsp16 inhibitors of SARS -CoV-2, SARS -CoV-1 and MERS-CoV from FDA-approved drugs using in silico and in vitro methods
  - Ejlal A. Omer, Sara Abdelfatah, Nasim Shahhamzehei, Axel Guthart, Kathrin Sutter, Hannah S. Schwarzer-Sperber, Roland Schwarzer, Thomas Efferth
  - Vol 189 - Article 118246
- - Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain?
  - Mahmoud Al-Khrasani, Nariman Essmat, Imre Boldizsár, Bence Tamás Varga, Yashar Chalabiani, Sarah Kadhim Abbood, Aliz Judit Ernyey, Kornél Király, Attila Máté, Pál Riba, Julia Timár, István Gyertyán, Ildikó Miklya, Carmela Parenti, Lorella Pasquinucci, Bence Ágg, Susanna Fürst, Péter Ferdinandy, E. Sylvester Vizi, Laszlo G. Harsing
  - Vol 189 - Article 118346
- - Targeting SARS-CoV-2 RNA-dependent RNA polymerase with the coumarin derivative BPR2-D2: Evidence from cell-based and enzymatic studies
  - Wen-Fang Tang, Hui-Ping Tsai, Yuan-Fan Chin, Shan-Ko Tsai, Cheng-Chin Lin, Son Tung Ngo, Po-Huang Liang, Jia-Rong Jheng, Chung-Fan Hsieh, Jin-Ching Lee, Yu-Hsiu Chang, Tein-Yao Chang, Chia-Yi Lin, Guan-Hua Lin, Jie-Yun Cai, Yu-Li Chen, Yuan-Siao Chen, Ping-Cheng Liu, Chuen-Mi Yang, Tolou Shadbahr, Jing Tang, Ling-Yu Wang, Cheng Cheung Chen, Shu-Chen Hsu, Hsin-Yi Lee, Wen-Chieh Wang, Quynh Mai Thai, Minh Quan Pham, Jim-Tong Horng
  - Vol 189 - Article 118252
- - SARS-CoV-2 S1 protein induces IgG-mediated platelet activation and is prevented by 1.8-cineole
  - Julie Petry, Maria Shoykhet, Tobias Weiser, Lena Griesbaum, Ali Bashiri Dezfouli, Admar Verschoor, Barbara Wollenberg
  - Vol 187 - Article 118100
- - The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2
  - Manish Dhawan, Nanamika Thakur, Manish Sharma, Ali A. Rabaan
  - Vol 185 - Article 117936
- - Subphenotypes of Long COVID and the clinical applications of probiotics
  - Hui Xuan Lim, Kanwal Khalid, Amar Daud Iskandar Abdullah, Learn-Han Lee, Raja Affendi Raja Ali
  - Vol 183 - Article 117855
- - Therapeutic oligonucleotide ASC1R shows excellent tolerability and remarkable efficacy in reducing SARS-CoV-2 mRNA levels in C57BL/6 mice
  - Veronika Nemethova, Petra Babiakova, Michal Selc, Kristina Jakic, Lucia Uhelska, Boglarka Teglasova, Peter Makovicky, Andrea Babelova, Filip Razga
  - Vol 180 - Article 117587
- - Identification of nitrile-containing isoquinoline-related natural product derivatives as coronavirus entry inhibitors in silico and in vitro
  - Nasim Shahhamzehei, Sara Abdelfatah, Hannah S. Schwarzer-Sperber, Kathrin Sutter, Rümeysa Yücer, Gerhard Bringmann, Roland Schwarzer, Thomas Efferth
  - Vol 180 - Article 117517
- - Macrolide resistance outcomes after the Covid-19 pandemic: A one health approach investigation
  - Sarah O. Rodrigues, Felipe R. Santiago, Monique S. Silva, Alex Sandro G. Lima, Lidiane E. Godoy, Michel De Waard, Dalia Fouad, Gaber E. Batiha, Tamara L. Santos, Jorge P. Pagnossa
  - Vol 180 - Article 117437
- - Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages
  - Jean-Sélim Driouich, Maxime Cochin, Guillaume Lingas, Léa Luciani, Cécile Baronti, Ornéllie Bernadin, Magali Gilles, Paola Mariela Saba Villarroel, Grégory Moureau, Paul-Rémi Petit, Axelle Dupont, Jacques Izopet, Nassim Kamar, Brigitte Autran, Gilles Paintaud, Sophie Caillard, Amandine le Bourgeois, Christophe Richez, Lionel Couzi, Aliénor Xhaard, Zora Marjanovic, Jerome Avouac, Caroline Jacquet, Dany Anglicheau, Morgane Cheminant, Stéphanie Nguyen, Benjamin Terrier, Jacques Eric Gottenberg, Caroline Besson, Sophie Letrou, Josephine Tine, Joe Miantezila Basilua, Denis Angoulvant, Coralie Tardivon, Gilles Blancho, Guillaume Martin-Blondel, Yazdan Yazdanpanah, France Mentré, Vincent Lévy, Franck Touret, Jérémie Guedj, Xavier de Lamballerie, Antoine Nougairède
  - Vol 177 - Article 116988
- - Antibody drugs targeting SARS-CoV-2: Time for a rethink?
  - Likeng Liang, Bo Wang, Qing Zhang, Shiwu Zhang, Sihe Zhang
  - Vol 176 - Article 116900
- - Repurposing anti-cancer porphyrin derivative drugs to target SARS-CoV-2 envelope
  - Diogo A. Mendonça, Iris Cadima-Couto, Carolina C. Buga, Zoe A. Arnaut, Fabio A. Schaberle, Luis G. Arnaut, Miguel A.R.B. Castanho, Christine Cruz-Oliveira
  - Vol 176 - Article 116768
- - Intranasal administration of Escherichia coli Nissle expressing the spike protein of SARS-CoV-2 induces long-term immunization and prevents spike protein-mediated lung injury in mice
  - Giovanni Sarnelli, Alessandro Del Re, Irene Palenca, Silvia Basili Franzin, Jie Lu, Luisa Seguella, Aurora Zilli, Marcella Pesce, Sara Rurgo, Giovanni Esposito, Walter Sanseverino, Giuseppe Esposito
  - Vol 174 - Article 116441
- - Emerging role of N6-methyladenosine RNA modification in regulation of SARS-CoV-2 infection and virus-host interactions
  - Jiayi Liu, Lingli Chen, Xiongmin Guo, Bingrong Zhao, Juan Jiang
  - Vol 173 - Article 116231
- - Recent advances in application of computer-aided drug design in anti-COVID-19 Virials Drug Discovery
  - Weiying Yang, Ye Wang, Dongfeng Han, Wenjing Tang, Lichao Sun
  - Vol 173 - Article 116423
- - Novel nitric oxide donors are coronary vasodilators that also bind to the papain-like protease of SARS-CoV-2
  - John F. Schmedtje, Fred Ciske, Kendall M. Muzzarelli, Zahra Assar
  - Vol 173 - Article 116378
- - Assessing medication use patterns by clinical outcomes severity among inpatients with COVID-19: A retrospective drug utilization study
  - Renato Ferreira-da-Silva, Priscila Maranhão, Cláudia Camila Dias, João Miguel Alves, Lígia Pires, Manuela Morato, Jorge Junqueira Polónia, Inês Ribeiro-Vaz
  - Vol 172 - Article 116242
- - Myocarditis and pericarditis risk with mRNA COVID-19 vaccination compared to unvaccinated individuals: A retrospective cohort study in a Spanish Tertiary Hospital
  - Mikel Urroz Elizalde, Francisco Javier Guijarro Eguinoa, Arturo Gómez López de las Huertas, María Jiménez-González, Elena Ramírez
  - Vol 171 - Article 116181
- - Recent advancements in the discovery of small-molecule non-nucleoside inhibitors targeting SARS-CoV-2 RdRp
  - Bangdi Zhou, Dianming Chen, Tingyan Zhang, Chenggui Song, Xianwu Zhang, Leying Lin, Jiuzhong Huang, Xiaopeng Peng, Yuanchang Liu, Gaorong Wu, Jingyuan Li, Weiming Chen
  - Vol 171 - Article 116180
- - Immunoregulatory effects of nanocurcumin in inflammatory milieu: Focus on COVID-19
  - Fahimeh Lavi Arab, Akram Hoseinzadeh, Fatemeh Sadat Mohammadi, Arezoo Rajabian, Arezoo Faridzadeh, Mahmoud Mahmoudi
  - Vol 171 - Article 116131
- - RETRACTED: Deaths induced by compassionate use of hydroxychloroquine during the first COVID-19 wave: An estimate
  - Alexiane Pradelle, Sabine Mainbourg, Steeve Provencher, Emmanuel Massy, Guillaume Grenet, Jean-Christophe Lega
  - Vol 171 - Article 116055
- - Effect of salidroside on neuroprotection and psychiatric sequelae during the COVID-19 pandemic: A review
  - Ting Zhu, Hui Liu, Shiman Gao, Ning Jiang, Shuai Chen, Weijie Xie
  - Vol 170 - Article 115999
- - Inhibition of SARS-CoV-2 infection and replication by Petasites hybridus CO2-extract (Ze 339)
  - Constanze A. Jakwerth, Vincent Grass, Anna Erb, Andreas Pichlmair, Georg Boonen, Veronika Butterweck, Carsten B. Schmidt-Weber
  - Vol 170 - Article 115959
- - Inhibition of furin-like enzymatic activities and SARS-CoV-2 infection by osthole and phenolic compounds with aryl side chains
  - Yuka Kiba, Takashi Tanikawa, Tsuyoshi Hayashi, Hitoshi Kamauchi, Taishi Seki, Ryuichiro Suzuki, Masashi Kitamura
  - Vol 169 - Article 115940
- - Adjunctive use of oral MAF is associated with no disease progression or mortality in hospitalized patients with COVID-19 pneumonia: The single-arm COral-MAF1 prospective trial
  - Lucrezia Spadera, Marina Lugarà, Maria Spadera, Mariano Conticelli, Gabriella Oliva, Vincenzo Bassi, Valentina Apuzzi, Francesco Calderaro, Olimpia Fattoruso, Pietro Guzzi, Maurizio D’Amora, Oriana Catapano, Roberta Marra, Maria Galdo, Michele Zappalà, Toshio Inui, Martin Mette, Giuseppe Vitiello, Maria Corvino, Giuseppe Tortoriello
  - Vol 169 - Article 115894
- - A prospective randomized, double-blind placebo-controlled study to evaluate the effectiveness of neuroprotective therapy using functional brain MRI in patients with post-covid chronic fatigue syndrome
  - M. Tanashyan, S. Morozova, A. Raskurazhev, P. Kuznetsova
  - Vol 168 - Article 115723
- - Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2
  - Melissa Baggieri, Silvia Gioacchini, Gigliola Borgonovo, Giorgia Catinella, Antonella Marchi, Pasquale Picone, Sonya Vasto, Raoul Fioravanti, Paola Bucci, Maedeh Kojouri, Roberto Giuseppetti, Emilio D’Ugo, Fausto Ubaldi, Sabrina Dallavalle, Domenico Nuzzo, Andrea Pinto, Fabio Magurano
  - Vol 168 - Article 115682
- - The potential role of ferroptosis in COVID-19-related cardiovascular injury
  - Lei Yang, Yunyi Wu, Weidong Jin, Nan Mo, Gaoqi Ye, Zixin Su, Lusheng Tang, Ying Wang, Yanchun Li, Jing Du
  - Vol 168 - Article 115637
- - Is neuropilin-1 the neuroimmune initiator of multi-system hyperinflammation in COVID-19?
  - Kiarash Saleki, Parsa Alijanizadeh, Abbas Azadmehr
  - Vol 167 - Article 115558
- - Post-COVID-19 syndrome management: Utilizing the potential of dietary polysaccharides
  - Kit-Leong Cheong, Biao Yu, Bo Teng, Suresh Veeraperumal, Baojun Xu, Saiyi Zhong, Karsoon Tan
  - Vol 166 - Article 115320
- - Role of SARS-COV-2 and ACE2 in the pathophysiology of peripheral vascular diseases
  - Hamid Tanzadehpanah, Elham Lotfian, Amir Avan, Sahar Saki, Sima Nobari, Roghaye Mahmoodian, Mohsen Sheykhhasan, Mohamad Hosein Shafiee Froutagh, Farzaneh Ghotbani, Raoufeh Jamshidi, Hanie Mahaki
  - Vol 166 - Article 115321
- - Eculizumab suppresses zymosan-induced release of inflammatory cytokines IL-1α, IL-1β, IFN-γ and IL-2 in autologous serum-substituted PBMC cultures: Relevance to cytokine storm in Covid-19
  - Tamás Bakos, Gergely T. Kozma, János Szebeni, Gábor Szénási
  - Vol 166 - Article 115294
- - Impact of methotrexate treatment on vaccines immunogenicity in adult rheumatological patients – Lessons learned from the COVID-19 pandemic
  - Jakub Wroński, Marzena Ciechomska, Ewa Kuca-Warnawin
  - Vol 165 - Article 115254
- - New perspective on the immunomodulatory activity of ginsenosides: Focus on effective therapies for post-COVID-19
  - Yixin Wang, Qin Han, Shuxia Zhang, Xiaoyan Xing, Xiaobo Sun
  - Vol 165 - Article 115154
- - Exploring the future of SARS-CoV-2 treatment after the first two years of the pandemic: A comparative study of alternative therapeutics
  - Benjamin Ayodipupo Babalola, Oluwamayowa Samuel Akinsuyi, Elizabeth Oreoluwa Folajimi, Folakemi Olujimi, Ahmed Adebisi Otunba, Bruno Chikere, Ibitayo Ajayi Adewumagun, Tosin Emmanuel Adetobi
  - Vol 165 - Article 115099
- - β-Cyclodextrins as affordable antivirals to treat coronavirus infection
  - Dalia Raïch-Regué, Raquel Tenorio, Isabel Fernández de Castro, Ferran Tarrés-Freixas, Martin Sachse, Daniel Perez-Zsolt, Jordana Muñoz-Basagoiti, Sara Y. Fernández-Sánchez, Marçal Gallemí, Paula Ortega-González, Alberto Fernández-Oliva, José A. Gabaldón, Estrella Nuñez-Delicado, Josefina Casas, Núria Roca, Guillermo Cantero, Mónica Pérez, Carla Usai, Cristina Lorca-Oró, Júlia-Vergara Alert, Joaquim Segalés, Jorge Carrillo, Julià Blanco, Bonaventura Clotet Sala, José P. Cerón-Carrasco, Nuria Izquierdo-Useros, Cristina Risco
  - Vol 164 - Article 114997
- - Bmal1 and Gut-lung axis in SARS-CoV-2 infection: New insight into the effects of melatonin on COVID-19 patients?
  - Mohammad Rafi Khezri, Reza Varzandeh, Morteza Ghasemnejad-Berenji
  - Vol 164 - Article 114291
- - Recuperative herbal formula Jing Si maintains vasculature permeability balance, regulates inflammation and assuages concomitants of “Long-Covid”
  - Chien-Yi Chiang, Yu-Jung Lin, Wen-Tsan Weng, Heng-Dao Lin, Cheng-You Lu, Wan-Jing Chen, Cheng Yen Shih, Pi-Yu Lin, Shinn-Zong Lin, Tsung-Jung Ho, Marthandam Asokan Shibu, Chih-Yang Huang
  - Vol 163 - Article 114752
- - The F/B ratio as a biomarker for inflammation in COVID-19 and T2D: Impact of metformin
  - Pavlo Petakh, Valentyn Oksenych, Aleksandr Kamyshnyi
  - Vol 163 - Article 114892
- - Intravenous immunoglobulins (IVIG) in severe/critical COVID-19 adult patients
  - Dorota Kwapisz, Joanna Bogusławska
  - Vol 163 - Article 114851
- - Fibrinolytic system and COVID-19: From an innovative view of epithelial ion transport
  - Yunmei Fu, Hao Xue, Tingyu Wang, Yan Ding, Yong Cui, Hongguang Nie
  - Vol 163 - Article 114863
- - Dendrobium officinale aqueous extract influences the immune response following vaccination against SARS-CoV-2
  - Xiaoping Gao, Ting Ye, Yu Lei, Qi Zhang, Yuanning Luo, Haiyan Yang, Xiaochun Zeng, Wen Zhou, Qinglian Wen, Jingbo Liu, Hong Xiong, Runlan Wan
  - Vol 162 - Article 114702
- - Reports analysis of psychotropic drugs related adverse reactions in Australia and Poland during the COVID 19 pandemic
  - Daria Schetz, Tara Elizabeth Scott, Wojciech Waldman, Jacek Sein Anand, Marek Wiergowski, Ivan Kocić
  - Vol 162 - Article 114681
- - Lung mesenchymal cells from patients with COVID-19 driven lung fibrosis: Several features with CTD-ILD derived cells but with higher response to fibrogenic signals and might be more pro-inflammatory
  - Sara Bozzini, Matteo Della Zoppa, Cecilia Bagnera, Eleonora Bozza, Stefania Croce, Chiara Valsecchi, Mirko Belliato, Laura Pandolfi, Patrizia Morbini, Patrizia Comoli, Maria Antonietta Avanzini, Federica Meloni
  - Vol 162 - Article 114640
- - FDA approved drugs with antiviral activity against SARS-CoV-2: From structure-based repurposing to host-specific mechanisms
  - Mahmoud S. Ahmed, Ayman B. Farag, Ian N. Boys, Ping Wang, Ivan Menendez-Montes, Ngoc Uyen Nhi Nguyen, Jennifer L. Eitson, Maikke B. Ohlson, Wenchun Fan, Matthew B. McDougal, Katrina Mar, Suwannee Thet, Francisco Ortiz, Soo Young Kim, Ashley Solmonson, Noelle S. Williams, Andrew Lemoff, Ralph J. DeBerardinis, John W. Schoggins, Hesham A. Sadek
  - Vol 162 - Article 114614
- - Paxlovid (Nirmatrelvir/Ritonavir): A new approach to Covid-19 therapy?
  - Seyed Mohammad Reza Hashemian, Amirhossein Sheida, Mohammad Taghizadieh, Mohammad Yousef Memar, Michael R. Hamblin, Hossein Bannazadeh Baghi, Javid Sadri Nahand, Zatollah Asemi, Hamed Mirzaei
  - Vol 162 - Article 114367
- - Ovatodiolide inhibits SARS-CoV-2 replication and ameliorates pulmonary fibrosis through suppression of the TGF-β/TβRs signaling pathway
  - Wei-Chung Chiou, Guan-Jhong Huang, Tein-Yao Chang, Tzu-Lan Hsia, Hao-You Yu, Jir-Mehng Lo, Pin-Kuei Fu, Cheng Huang
  - Vol 161 - Article 114481
- - Computer-aided drug design for the pain-like protease (PL^pro) inhibitors against SARS-CoV-2
  - Hongwei Gao, Renhui Dai, Ruiling Su
  - Vol 159 - Article 114247
- - SARS-CoV-2 E protein: Pathogenesis and potential therapeutic development
  - Shilin Zhou, Panpan Lv, Mingxue Li, Zihui Chen, Hong Xin, Svetlana Reilly, Xuemei Zhang
  - Vol 159 - Article 114242
- - The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany
  - Jonathan Orschiedt, Elizabeth Jacyshyn-Owen, Maria Kahn, Sven Jansen, Natalie Joschko, Markus Eberl, Sebastian Schneeweiss, Benjamin Friedrich, Tjalf Ziemssen
  - Vol 158 - Article 114129
- - Humulus lupus extract rich in xanthohumol improves the clinical course in critically ill COVID-19 patients
  - Wojciech Dabrowski, Mariusz Gagos, Dorota Siwicka-Gieroba, Mariusz Piechota, Jan Siwiec, Magdalena Bielacz, Katarzyna Kotfis, Andrzej Stepulak, Luiza Grzycka-Kowalczyk, Andrzej Jaroszynski, Manu LNG Malbrain
  - Vol 158 - Article 114082
- - A potential host and virus targeting tool against COVID-19: Chemical characterization, antiviral, cytoprotective, antioxidant, respiratory smooth muscle relaxant effects of Paulownia tomentosa Steud
  - Fabio Magurano, Matteo Micucci, Domenico Nuzzo, Melissa Baggieri, Pasquale Picone, Silvia Gioacchini, Raoul Fioravanti, Paola Bucci, Maedeh Kojouri, Michele Mari, Michele Retini, Roberta Budriesi, Laura Beatrice Mattioli, Ivan Corazza, Valentina Di Liberto, Luigi Todaro, Roberto Giuseppetti, Emilio D’Ugo, Antonella Marchi, Marisabel Mecca, Maurizio D’Auria
  - Vol 158 - Article 114083
- - Teicoplanin derivatives block spike protein mediated viral entry as pan-SARS-CoV-2 inhibitors
  - Ling Ma, Yali Li, Ting Shi, Zhiling Zhu, Jianyuan zhao, Yongli Xie, Jiajia Wen, Saisai Guo, Jing Wang, Jiwei Ding, Chen Liang, Guangzhi Shan, Quanjie Li, Mei Ge, Shan Cen
  - Vol 158 - Article 114213
- - From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era
  - Ganggang Miao, Zhiqiang Chen, Hengsong Cao, Wenhao Wu, Xi Chu, Hanyuan Liu, Leyao Zhang, Hongfei Zhu, Hongzhou Cai, Xiaolan Lu, Junfeng Shi, Yuan Liu, Tingting Feng
  - Vol 158 - Article 114208
- - Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
  - Ahmed I. Abulsoud, Hussein M. El-Husseiny, Ahmed A. El-Husseiny, Hesham A. El-Mahdy, Ahmed Ismail, Samy Y. Elkhawaga, Emad Gamil Khidr, Doaa Fathi, Eman A. Mady, Agnieszka Najda, Mohammad Algahtani, Abdulrahman Theyab, Khalaf F. Alsharif, Ashraf Albrakati, Roula Bayram, Mohamed M. Abdel-Daim, Ahmed S. Doghish
  - Vol 157 - Article 113977
- - Identification of phytochemicals in Qingfei Paidu decoction for the treatment of coronavirus disease 2019 by targeting the virus-host interactome
  - Yuyun Li, Yan Wu, Siyan Li, Yibin Li, Xin Zhang, Zeren Shou, Shuyin Gu, Chenliang Zhou, Daohua Xu, Kangni Zhao, Suiyi Tan, Jiayin Qiu, Xiaoyan Pan, Lin Li
  - Vol 156 - Article 113946
- - The role of SARS-CoV-2 accessory proteins in immune evasion
  - Milad Zandi, Maryam Shafaati, Davood Kalantar-Neyestanaki, Hossein Pourghadamyari, Mona Fani, Saber Soltani, Hassan Kaleji, Samaneh Abbasi
  - Vol 156 - Article 113889
- - Highly pathogenic coronaviruses and the kidney
  - Fang Wang, Xiao-Guo Suo, Cong Wang, Jia-Nan Wang, Xiao-Yan He, Fa-Cai Wang, Juan Jin, Jia-Gen Wen, Wei-Jian Ni, Bing-Xiang Shen, Xiao-Ming Meng
  - Vol 156 - Article 113807
- - Ganoderma microsporum immunomodulatory protein acts as a multifunctional broad-spectrum antiviral against SARS-CoV-2 by interfering virus binding to the host cells and spike-mediated cell fusion
  - Ha Phan Thanh Ho, Di Ngoc Kha Vo, Tung-Yi Lin, Jo-Ning Hung, Ya-Hui Chiu, Ming-Han Tsai
  - Vol 155 - Article 113766
- - The landscape of potential health benefits of carotenoids as natural supportive therapeutics in protecting against Coronavirus infection
  - Louise W. Lu, Yao Gao, Siew-Young Quek, Meika Foster, Charles T. Eason, Min Liu, Mingfu Wang, Jie-Hua Chen, Feng Chen
  - Vol 154 - Article 113625
- - Genome-wide transcriptional profiling of pulmonary functional sequelae in ARDS- secondary to SARS-CoV-2 infection
  - María C. García-Hidalgo, Rafael Peláez, Jessica González, Sally Santisteve, Iván D. Benítez, Marta Molinero, Manel Perez-Pons, Thalía Belmonte, Gerard Torres, Anna Moncusí-Moix, Clara Gort-Paniello, Maria Aguilà, Faty Seck, Paola Carmona, Jesús Caballero, Carme Barberà, Adrián Ceccato, Laia Fernández-Barat, Ricard Ferrer, Dario Garcia-Gasulla, Jose Ángel Lorente-Balanza, Rosario Menéndez, Ana Motos, Oscar Peñuelas, Jordi Riera, Jesús F. Bermejo-Martin, Antoni Torres, Ferran Barbé, David de Gonzalo-Calvo, Ignacio M. Larráyoz
  - Vol 154 - Article 113617
- - The favorable impacts of silibinin polyphenols as adjunctive therapy in reducing the complications of COVID-19: A review of research evidence and underlying mechanisms
  - Vali Musazadeh, Arash Karimi, Nasim bagheri, Jaber Jafarzadeh, Sarvin Sanaie, Mahdi Vajdi, Mozhde Karimi, Hamid Reza Niazkar
  - Vol 154 - Article 113593
- - COVID-19-associated liver injury: Clinical characteristics, pathophysiological mechanisms and treatment management
  - Penghui Li, Ying Liu, Ziqi Cheng, Xiaorui Yu, Yinxiong Li
  - Vol 154 - Article 113568
- - Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated?
  - Neda Omidian, Pantea Mohammadi, Mona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh
  - Vol 154 - Article 113534
- - RETRACTED: Omicron variant (B.1.1.529) and its sublineages: What do we know so far amid the emergence of recombinant variants of SARS-CoV-2?
  - Manish Dhawan, AbdulRahman A. Saied, Saikat Mitra, Fahad A. Alhumaydhi, Talha Bin Emran, Polrat Wilairatana
  - Vol 154 - Article 113522
- - Recent advances in point of care testing for COVID-19 detection
  - Renata Salgado Fernandes, Juliana de Oliveira Silva, Karina Braga Gomes, Ricardo Bentes Azevedo, Danyelle M. Townsend, Adriano de Paula Sabino, Andre Luis Branco de Barros
  - Vol 153 - Article 113538
- - A comprehensive insight into current control of COVID-19: Immunogenicity, vaccination, and treatment.
  - Yasser Mohamed, Yousra A. El-Maradny, Ahmed K. Saleh, AbdElAziz A. Nayl, Hamada El-Gendi, Esmail M. El-Fakharany
  - Vol 153 - Article 113499
- - Early reduction of estimated Glomerular Filtration Rate (eGFR) predicts poor outcome in acutely ill hospitalized COVID-19 patients firstly admitted to medical regular wards (eGFR-COV19 study)
  - Francesco Cei, Ludia Chiarugi, Simona Brancati, Maria Silvia Montini, Silvia Dolenti, Daniele Di Stefano, Salvatore Beatrice, Irene Sellerio, Valentina Messiniti, Marco Maria Gucci, Giulia Vannini, Rinaldo Lavecchia, Elisa Cioni, Chiara Mattaliano, Giulia Pelagalli, Grazia Panigada, Emanuele Murgo, Gianluigi Mazzoccoli, Giancarlo Landini, Roberto Tarquini
  - Vol 153 - Article 113454
- - Study on the potential of Sanghuangporus sanghuang and its components as COVID-19 spike protein receptor binding domain inhibitors
  - Liang-Hsuan Chien, Jeng-Shyan Deng, Wen-Ping Jiang, Chin-Chu Chen, Ya-Ni Chou, Jaung-Geng Lin, Guan-Jhong Huang
  - Vol 153 - Article 113434
- - Virtual screening of substances used in the treatment of SARS-CoV-2 infection and analysis of compounds with known action on structurally similar proteins from other viruses
  - Paul Andrei Negru, Denisa Claudia Miculas, Tapan Behl, Alexa Florina Bungau, Ruxandra-Cristina Marin, Simona Gabriela Bungau
  - Vol 153 - Article 113432
- - Epigenetic activation of antiviral sensors and effectors of interferon response pathways during SARS-CoV-2 infection
  - Jan Bińkowski, Olga Taryma-Leśniak, Karolina Łuczkowska, Anna Niedzwiedź, Kacper Lechowicz, Dominik Strapagiel, Justyna Jarczak, Veronica Davalos, Aurora Pujol, Manel Esteller, Katarzyna Kotfis, Bogusław Machaliński, Miłosz Parczewski, Tomasz K. Wojdacz
  - Vol 153 - Article 113396
- - Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies
  - Hatixhe Latifi-Pupovci
  - Vol 153 - Article 113368
- - A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19
  - Faheem Ahmed, Afaque Manzoor Soomro, Abdul Rahim Chethikkattuveli Salih, Anupama Samantasinghar, Arun Asif, In Suk Kang, Kyung Hyun Choi
  - Vol 153 - Article 113350
- - Treatment with metformin glycinate reduces SARS-CoV-2 viral load: An in vitro model and randomized, double-blind, Phase IIb clinical trial
  - Claudia Ventura-López, Karla Cervantes-Luevano, Janet S. Aguirre-Sánchez, Juan C. Flores-Caballero, Carolina Alvarez-Delgado, Johanna Bernaldez-Sarabia, Noemí Sánchez-Campos, Laura A. Lugo-Sánchez, Ileana C. Rodríguez-Vázquez, Jose G. Sander-Padilla, Yulia Romero-Antonio, María M. Arguedas-Núñez, Jorge González-Canudas, Alexei F. Licea-Navarro
  - Vol 152 - Article 113223
- - Plasmatic renin-angiotensin system in normotensive and hypertensive patients hospitalized with COVID-19
  - Mauro G. Silva, Gerardo R. Corradi, Juan I. Pérez Duhalde, Myriam Nuñez, Eliana M. Cela, Daniel H. Gonzales Maglio, Ana Brizzio, Martin R. Salazar, Walter G. Espeche, Mariela M. Gironacci
  - Vol 152 - Article 113201
- - Self-derived peptides from the SARS-CoV-2 spike glycoprotein disrupting shaping and stability of the homotrimer unit
  - Monikaben Padariya, Alison Daniels, Christine Tait-Burkard, Ted Hupp, Umesh Kalathiya
  - Vol 151 - Article 113190
- - Reviving the mutual impact of SARS-COV-2 and obesity on patients: From morbidity to mortality
  - Tapan Behl, Sachin Kumar, Sukhbir Singh, Saurabh Bhatia, Ali Albarrati, Mohammed Albratty, Abdulkarim M. Meraya, Asim Najmi, Simona Bungau
  - Vol 151 - Article 113178
- - Immune-based therapeutic approaches in COVID-19
  - Aysan Moeinafshar, Niloufar Yazdanpanah, Nima Rezaei
  - Vol 151 - Article 113107
- - High-throughput drug screening allowed identification of entry inhibitors specifically targeting different routes of SARS-CoV-2 Delta and Omicron/BA.1
  - Maria Kuzikov, Jannis Woens, Andrea Zaliani, Julia Hambach, Thomas Eden, Boris Fehse, Bernhard Ellinger, Kristoffer Riecken
  - Vol 151 - Article 113104
- - COVID-19 and diabetes: Association intensify risk factors for morbidity and mortality
  - Prateek Sharma, Tapan Behl, Neelam Sharma, Sukhbir Singh, Ajmer Singh Grewal, Ali Albarrati, Mohammed Albratty, Abdulkarim M. Meraya, Simona Bungau
  - Vol 151 - Article 113089
- - Molnupiravir combined with different repurposed drugs further inhibits SARS-CoV-2 infection in human nasal epithelium in vitro
  - Hulda R. Jonsdottir, Denise Siegrist, Thomas Julien, Blandine Padey, Mendy Bouveret, Olivier Terrier, Andres Pizzorno, Song Huang, Kirandeep Samby, Timothy N.C. Wells, Bernadett Boda, Manuel Rosa-Calatrava, Olivier B. Engler, Samuel Constant
  - Vol 150 - Article 113058
- - Ursodeoxycholic acid ameliorates cell migration retarded by the SARS-CoV-2 spike protein in BEAS-2B human bronchial epithelial cells
  - Pham Xuan Thuy, Tran Duc Duy Bao, Eun-Yi Moon
  - Vol 150 - Article 113021
- - Seroprevalence of SARS-CoV-2-specific antibodies and vaccination-related adverse events in systemic lupus erythematosus and rheumatoid arthritis
  - Peng Wang, Jing Ni, Ya-Ya Chu, Qing-Qing Chen, Guo-Cui Wu, Yang Fang, Cong Chen, Ruo-Di Zhang, Ling-Qiong Jiang, Yan Zhao, Xi Fang, Jun He, De-Guang Wang, Gui-Hong Wang, Hai-Feng Pan
  - Vol 150 - Article 112997
- - Adamalysins in COVID-19 – Potential mechanisms behind exacerbating the disease
  - Ivo Ricardo de Seabra Rodrigues Dias, Zhijian Cao, Hang Fai Kwok
  - Vol 150 - Article 112970
- - Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D
  - Montserrat Torres, Guiomar Casado, Lorena Vigón, Sara Rodríguez-Mora, Elena Mateos, Fernando Ramos-Martín, Daniel López-Wolf, José Sanz-Moreno, Pablo Ryan-Murua, María Luisa Taboada-Martínez, María Rosa López-Huertas, Miguel Cervero, Mayte Coiras, on behalf of Multidisciplinary Group of Study of COVID-19 (MGS-COVID), Contributing members of the Multidisciplinary Group of Study of COVID-19 (in alphabetical order), David Alonso-Menchén, Sandra Arévalo Camacho, Cristina Avila Calzada, José Antonio Barbado Albaladejo, Natalia Blanca López, Irene Cañamares Orbis, Gema Carrillo Blanco, Almudena Cascajero Díaz, María Teresa Chica Burguillo, Ana Corrochano García, Sara Corredera García, Victor Díez Viñas, Marta Gómez-Alvarez Domínguez, Claudia Patricia Fernández Fernández, Yanira Fernández Mondelo, Eva Fonseca Aizpuri, Concepción García Lacalle, Javier García-Pérez, Cristina Helguera Amezua, Francisco José Hidalgo Correas, Amparo Lucena Campillo, Mariano Matarranz del Amo, Oriol Martín Sagarra, Emilio José Martínez Martín, José Javier Martínez Simón, María Novella-Mena, Virginia Pardo Guimera, María Luisa Pinillos Pardo, Fr`ancisca Ramírez Fuentes, Daniel Renuncio García, María Angeles Rodríguez Dávila, Almudena Roger Revilla, Lourdes Sampablo Valverde, José Sanz Moreno, Rafael Torres Perea, Jorge Valencia La Rosa, María Velasco Arribas, Ana Villanueva Fernández-Ardavín
  - Vol 150 - Article 112965
- - Advanced cell therapy with low tissue factor loaded product NestaCell® does not confer thrombogenic risk for critically ill COVID-19 heparin-treated patients
  - Rodrigo Pinheiro Araldi, Benedito Carlos Prezoto, Vivian Gonzaga, Bruna Policiquio, Thais Biude Mendes, Fernanda D’Amélio, Hugo Vigerelli, Mariana Viana, Cristiane Wenceslau Valverde, Eduardo Pagani, Irina Kerkis
  - Vol 149 - Article 112920
- - Lithium salts as a treatment for COVID-19: Pre-clinical outcomes
  - O. Soriano-Torres, E. Noa Romero, NL González Sosa, JM Enríquez Puertas, A. Fragas Quintero, M. García Montero, D. Martín Alfonso, Y. Infante Hernández, M. Lastre, L. Rodríguez-Pérez, Y. Borrego, VE González, IG Vega, R. Ramos Pupo, LM Reyes, MT Zumeta Dubé, Amaro Hernández, I. García de la Rosa, A. Minguez Suárez, LA Alarcón Camejo, M. Rodríguez, R. Oliva Hernández, CE Rudd, O. Pérez
  - Vol 149 - Article 112872
- - Epidemiology, clinical ramifications, and cellular pathogenesis of COVID-19 mRNA-vaccination-induced adverse cardiovascular outcomes: A state-of-the-heart review
  - Talal Almas, Sarah Rehman, Eyad Mansour, Tarek Khedro, Ali Alansari, Jahanzeb Malik, Norah Alshareef, Vikneswaran Raj Nagarajan, Abdulla Hussain Al-Awaid, Reema Alsufyani, Majid Alsufyani, Ali Rifai, Ahlam Alzahrani, Dhineswaran Raj Nagarajan, Tala Abdullatif, Varman Gunasaegaram, Enaam Alzadjali, Arthi Subramanian, Abida Rahman, Yasar Sattar, Jason Galo, Hafeez Ul Hassan Virk, M. Chadi Alraies
  - Vol 149 - Article 112843
- - Potential inhibitor for blocking binding between ACE2 and SARS-CoV-2 spike protein with mutations
  - Ming-Shao Tsai, Wei-Tai Shih, Yao-Hsu Yang, Yu-Shih Lin, Geng-He Chang, Cheng-Ming Hsu, Reming-Albert Yeh, Li-Hsin Shu, Yu-Ching Cheng, Hung-Te Liu, Yu-Huei Wu, Yu-Heng Wu, Rou-Chen Shen, Ching-Yuan Wu
  - Vol 149 - Article 112802
- - Traditional Chinese medicine against COVID-19: Role of the gut microbiota
  - Zhihua Yang, Yangxi Liu, Lin Wang, Shanshan Lin, Xiangdong Dai, Haifeng Yan, Zhao Ge, Qiuan Ren, Hui Wang, Feng Zhu, Shuping Wang
  - Vol 149 - Article 112787
- - Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial study
  - Reza Ramazani Khorshiddoust, Saleh Ramazani Khorshiddoust, Tahereh Hosseinabadi, Faezeh Mottaghitalab, Farzad Mokhtari, Fatemeh Azadinia, Hossein Mozdarani, Mohammad Shabani, Hamid Emadi-Kouchak, Bahram Taheri, Fatemeh Khani-Juyabad, Mina Amjadi Kashani, Arezoo Sadoughi, Sorour Zamanizadeh, Hadyeh Maddah, Maedeh Aminzadeh, Maryam Khanaki, Sabereh Saremi, Anahita Pashaee Rad, Ali Fatehi, Melika Ghaznavi Rad, Masoud Haftbaradaran, Mehran Khosroshahi, Mahtab Sadeghi, Majid Aminnayeri, Sirous Jafari, Fereshteh Ghiasvand, Arash Seifi, Sara Ghaderkhani, Seyed Ali Dehghan Manshadi, Mohammadreza Salehi, Ladan Abbasian, Malihe Hasannezhad, Mohsen Meidani, Mahboubeh Hajiabdolbaghi, Zahra Ahmadinejad, Masoud Parash, Zahra Sedighi, Abdorreza Mohammadian
  - Vol 149 - Article 112729
- - The potential role of resveratrol as supportive antiviral in treating conditions such as COVID-19 – A formulator’s perspective
  - Roy van Brummelen, Anna C. van Brummelen
  - Vol 148 - Article 112767
- - Muscle pain and muscle weakness in COVID19 patients: Cross-talk with statins – Preliminary results
  - Schetz Daria, Sztormowska-Achranowicz Katarzyna, Foerster Jerzy, Kocić Ivan
  - Vol 148 - Article 112757
- - Ex-vivo mucolytic and anti-inflammatory activity of BromAc in tracheal aspirates from COVID-19
  - Jordana Grazziela A. Coelho dos Reis, Geovane Marques Ferreira, Alice Aparecida Lourenço, Ágata Lopes Ribeiro, Camila Pacheco da Silveira Martins da Mata, Patrícia de Melo Oliveira, Daisymara Priscila de Almeida Marques, Linziane Lopes Ferreira, Felipe Alves Clarindo, Murillo Ferreira da Silva, Heitor Portella Póvoas Filho, Nilson Roberto Ribeiro Oliveira, Maisah Meyhr D’Carmo Sodré, Sandra Rocha Gadelha, George Rego Albuquerque, Bianca Mendes Maciel, Ana Paula Melo Mariano, Mylene de Melo Silva, Renato Fontana, Lauro Juliano Marin, Renata Santiago Alberto Carlos, Amanda Teixeira Sampaio Lopes, Fabrício Barbosa Ferreira, Uener Ribeiro dos Santos, Íris Terezinha Santos de Santana, Hllytchaikra Ferraz Fehlberg, Rachel Passos Rezende, João Carlos T. Dias, Eduardo Gross, Gisele Assis Castro Goulart, Marie Gabriele Santiago, Ana Paula Motta Lavigne de Lemos, Aline O. da Conceição, Carla Cristina Romano, Luciana Debortoli de Carvalho, Olindo Assis Martins Filho, Claudio Almeida Quadros, David L. Morris, Sarah J. Valle
  - Vol 148 - Article 112753
- - Role of the renin-angiotensin system in NETosis in the coronavirus disease 2019 (COVID-19)
  - Qingguang Zhang, Shuang Ling, Kaili Hu, Jun Liu, Jin-Wen Xu
  - Vol 148 - Article 112718
- - Therapeutic dilemmas in addressing SARS-CoV-2 infection: Favipiravir versus Remdesivir
  - Paul Andrei Negru, Andrei-Flavius Radu, Cosmin Mihai Vesa, Tapan Behl, Mohamed M. Abdel-Daim, Aurelia Cristina Nechifor, Laura Endres, Manuela Stoicescu, Bianca Pasca, Delia Mirela Tit, Simona Gabriela Bungau
  - Vol 147 - Article 112700
- - Natural products can be used in therapeutic management of COVID-19: Probable mechanistic insights
  - Sabeeha Ali, Manzar Alam, Fatima Khatoon, Urooj Fatima, Abdelbaset Mohamed Elasbali, Mohd Adnan, Asimul Islam, Md. Imtaiyaz Hassan, Mejdi Snoussi, Vincenzo De Feo
  - Vol 147 - Article 112658
- - Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
  - Thuy Trang Nguyen, Trang Ho Thu Quach, Thanh Mai Tran, Huynh Ngoc Phuoc, Ha Thi Nguyen, Tuong Kha Vo, Giau Van Vo
  - Vol 147 - Article 112650
- - Targeting chronic COVID-19 lung injury; Tofacitinib can be used against tissue-resident memory T cells
  - Sepideh Zununi Vahed, Seyed Mahdi Hosseiniyan Khatibi, Elham Ahmadian, Mohammadreza Ardalan
  - Vol 147 - Article 112614
- - A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies
  - Chang-Xing Li, Sobia Noreen, Li-Xue Zhang, Muhammad Saeed, Pei-Feng Wu, Muhammad Ijaz, Dong-Fang Dai, Irsah Maqbool, Asadullah Madni, Faizan Akram, Muhammad Naveed, Jian-Hua Li
  - Vol 146 - Article 112550
- - Pulmonary artery targeted therapy in treatment of COVID-19 related ARDS. Literature review
  - Oskar Puk, Aleksandra Nowacka, Klaudia Smulewicz, Katarzyna Mocna, Wiktor Bursiewicz, Natalia Kęsy, Justyna Kwiecień, Michał Wiciński
  - Vol 146 - Article 112592
- - Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort
  - Sonsoles Salto-Alejandre, Zaira R. Palacios-Baena, José Ramón Arribas, Juan Berenguer, Jordi Carratalà, Inmaculada Jarrín, Pablo Ryan, Marta de Miguel-Montero, Jesús Rodríguez-Baño, Jerónimo Pachón, for the COVID-19@Spain Study Group
  - Vol 146 - Article 112572
- - Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines
  - Mohammad Reza Zinatizadeh, Peyman Kheirandish Zarandi, Maryam Zinatizadeh, Mohammad Hadi Yousefi, Jaffar Amani, Nima Rezaei
  - Vol 146 - Article 112527
- - Interaction of SARS-CoV-2 with cardiomyocytes: Insight into the underlying molecular mechanisms of cardiac injury and pharmacotherapy
  - Abdulhamid Abdi, Shahad AlOtaiby, Firas Al Badarin, Ali Khraibi, Hamdan Hamdan, Moni Nader
  - Vol 146 - Article 112518
- - RdRp inhibitors and COVID-19: Is molnupiravir a good option?
  - Seyed Mohammad Reza Hashemian, Mohammad Hossein Pourhanifeh, Michael R. Hamblin, Mohammad Karim Shahrzad, Hamed Mirzaei
  - Vol 146 - Article 112517
- - Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies
  - Md. Nasir Ahmed, Rownak Jahan, Veeranoot Nissapatorn, Polrat Wilairatana, Mohammed Rahmatullah
  - Vol 146 - Article 112507
- - Mortality risk and antibiotic use for COVID-19 in hospitalized patients over 80
  - Andreea Rosca, Thibaut Balcaen, Jean-Philippe Lanoix, Audrey Michaud, Julien Moyet, Ingrid Marcq, Jean-Luc Schmit, Frederic Bloch, Guillaume Deschasse
  - Vol 146 - Article 112481
- - Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
  - Masoumeh Farahani, Zahra Niknam, Leila Mohammadi Amirabad, Nasrin Amiri-Dashatan, Mehdi Koushki, Mohadeseh Nemati, Fahima Danesh Pouya, Mostafa Rezaei-Tavirani, Yousef Rasmi, Lobat Tayebi
  - Vol 145 - Article 112420
- - Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications
  - Jamal Majidpoor, Keywan Mortezaee
  - Vol 145 - Article 112419
- - Chemically modified mRNA beyond COVID-19: Potential preventive and therapeutic applications for targeting chronic diseases
  - Dana Elkhalifa, Menatallah Rayan, Ahmed T. Negmeldin, Abdelbary Elhissi, Ashraf Khalil
  - Vol 145 - Article 112385
- - Beneficial effects of novel aureobasidium pullulans strains produced beta-1,3-1,6 glucans on interleukin-6 and D-dimer levels in COVID-19 patients; results of a randomized multiple-arm pilot clinical study
  - Kadalraja Raghavan, Vidyasagar Devaprasad Dedeepiya, Vaddi Suryaprakash, Kosagi-Sharaf Rao, Nobunao Ikewaki, Tohru Sonoda, Gary A. Levy, Masaru Iwasaki, Rajappa Senthilkumar, Senthilkumar Preethy, Samuel JK Abraham
  - Vol 145 - Article 112243
- - A comprehensive review on efficient approaches for combating coronaviruses
  - Mahdi Pouresmaieli, Elena Ekrami, Ali Akbari, Negin Noorbakhsh, Negin Borzooee Moghadam, Matin Mamoudifard
  - Vol 144 - Article 112353
- - Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19
  - Khadijeh Koushki, Maryam Salemi, Seyed Mohammad Miri, Yaser Arjeini, Mohsen Keshavarz, Amir Ghaemi
  - Vol 144 - Article 112346
- - Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential
  - Olexandr Kamyshnyi, Victoriya Matskevych, Tetyana Lenchuk, Olha Strilbytska, Kenneth Storey, Oleh Lushchak
  - Vol 144 - Article 112230
- - Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperative
  - Isaac Kyei-Barffour, Samuel Akwetey Addo, Enoch Aninagyei, George Ghartey-Kwansah, Desmond Omane Acheampong
  - Vol 144 - Article 112282
- - Clinical drug therapies and biologicals currently used or in clinical trial to treat COVID-19
  - Rory J. Malek, Colin A. Bill, Charlotte M. Vines
  - Vol 144 - Article 112276
- - Role of microRNAs in COVID-19 with implications for therapeutics
  - Nahid Arghiani, Tracy Nissan, Maryam M. Matin
  - Vol 144 - Article 112247
- - A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage
  - Yuval Ishay, Assaf Potruch, Asaf Schwartz, Marc Berg, Khurram Jamil, Samuel Agus, Yaron Ilan
  - Vol 143 - Article 112228
- - Cinnamon and its possible impact on COVID-19: The viewpoint of traditional and conventional medicine
  - Maryam Yakhchali, Zahra Taghipour, Mehran Mirabzadeh Ardakani, Mahdi Alizadeh Vaghasloo, Mahdi Vazirian, Sima Sadrai
  - Vol 143 - Article 112221
- - Arginine vasopressin and pathophysiology of COVID-19: An innovative perspective
  - Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Safaa Qusti, Eida M. Alshammari, Francis O. Atanu, Gaber El-Saber Batiha
  - Vol 143 - Article 112193
- - SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines
  - Abbas Khan, Taimoor Khan, Shughla Ali, Summiya Aftab, Yanjing Wang, Wang Qiankun, Mazhar Khan, Muhammad Suleman, Shahid Ali, Wang Heng, Syed Shujait Ali, Dong-Qing Wei, Anwar Mohammad
  - Vol 143 - Article 112176
- - RETRACTED: Nanoparticles as an effective drug delivery system in COVID-19
  - Neehasri Kumar Chowdhury, Reshma Choudhury, Gaurav Ambadas Sonawane, Shankar Mavinamar, Xiaoming Lyu, Ramendra Pati Pandey, Chung-Ming Chang
  - Vol 143 - Article 112162
- - Neurokinin-1 Receptor as a potential drug target for COVID-19 treatment
  - Riffat Mehboob
  - Vol 143 - Article 112159
- - A mini-review on the impact of COVID 19 on vital organs
  - Muhammad Dawood Shah, Aini Simon Sumeh, Muhammad Sheraz, Muthu Subash Kavitha, Balu Alagar Venmathi Maran, Kenneth Francis Rodrigues
  - Vol 143 - Article 112158
- - Potential of herbal products in prevention and treatment of COVID-19. Literature review
  - Aleksander Gajewski, Anna Kośmider, Aleksandra Nowacka, Oskar Puk, Michał Wiciński
  - Vol 143 - Article 112150
- - Recent advances in management of COVID-19: A review
  - Soraya Mouffak, Qamar Shubbar, Ekram Saleh, Raafat El-Awady
  - Vol 143 - Article 112107
- - Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs
  - Suvasmita Rath, Venkateswarlu Perikala, Atala Bihari Jena, Jagneshwar Dandapat
  - Vol 143 - Article 112095
- - MMP-2 and MMP-9 levels in plasma are altered and associated with mortality in COVID-19 patients
  - Carolina D`Avila-Mesquita, Ariel E.S. Couto, Ligia C.B. Campos, Tauana F. Vasconcelos, Jessyca Michelon-Barbosa, Carlos A.C. Corsi, Fabiola Mestriner, Bruno C. Petroski-Moraes, Maria J. Garbellini-Diab, Daniel M.S. Couto, Maria C. Jordani, Denise Ferro, Lourenço Sbragia, Edwaldo E. Joviliano, Paulo R. Evora, Rodrigo de Carvalho Santana, Olindo Assis Martins-Filho, Katarzyna Polonis, Mayra G. Menegueti, Mauricio S. Ribeiro, Maria Auxiliadora-Martins, Christiane Becari
  - Vol 142 - Article 112067
- - Repurposing methylene blue in the management of COVID-19: Mechanistic aspects and clinical investigations
  - Neha Dabholkar, Srividya Gorantla, Sunil Kumar Dubey, Amit Alexander, Rajeev Taliyan, Gautam Singhvi
  - Vol 142 - Article 112023
- - COVID-19 challenges and its therapeutics
  - Sabi Ur Rehman, Shaheed Ur Rehman, Hye Hyun Yoo
  - Vol 142 - Article 112015
- - GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2
  - Ming-Shao Tsai, Yao-Hsu Yang, Yu-Shih Lin, Geng-He Chang, Cheng-Ming Hsu, Reming-Albert Yeh, Li-Hsin Shu, Yu-Ching Cheng, Hung-Te Liu, Yu-Huei Wu, Yu-Heng Wu, Rou-Chen Shen, Ching-Yuan Wu
  - Vol 142 - Article 112011
- - Interleukin-17A (IL-17A): A silent amplifier of COVID-19
  - Francesco Maione, Gian Marco Casillo, Federica Raucci, Cristian Salvatore, Giovanna Ambrosini, Luisa Costa, Raffaele Scarpa, Francesco Caso, Mariarosaria Bucci
  - Vol 142 - Article 111980
- - Kidney injury in COVID-19 patients, drug development and their renal complications: Review study
  - Zeynab Mohamadi Yarijani, Houshang Najafi
  - Vol 142 - Article 111966
- - Potential protective role of the anti-PD-1 blockade against SARS-CoV-2 infection
  - Annoor Awadasseid, Qiang Yin, Yanling Wu, Wen Zhang
  - Vol 142 - Article 111957
- - In silico drug repurposing in COVID-19: A network-based analysis
  - Pasquale Sibilio, Simone Bini, Giulia Fiscon, Marialuisa Sponziello, Federica Conte, Valeria Pecce, Cosimo Durante, Paola Paci, Rosa Falcone, Giuseppe Danilo Norata, Lorenzo Farina, Antonella Verrienti
  - Vol 142 - Article 111954
- - A secondary approach with conventional medicines and supplements to recuperate current COVID-19 status
  - Apu Chowdhury, Muhammad Sajid, Nabila Jahan, Temitope Isaac Adelusi, Pulak Maitra, Guolian Yin, Xudong Wu, Yuan Gao, Sicen Wang
  - Vol 142 - Article 111956
- - Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2
  - Javier T. Granados-Riveron, Guillermo Aquino-Jarquin
  - Vol 142 - Article 111953
- - Lecithinized superoxide dismutase in the past and in the present: Any role in the actual pandemia of COVID-19?
  - Ilaria Farella, Raffaella Panza, Manuela Capozza, Nicola Laforgia
  - Vol 141 - Article 111922
- - Identification of oligopeptides from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) non structural protein 8 (NSP8) and their similarities with type 1 angiotensin II receptor key sites
  - Ammar Achour
  - Vol 141 - Article 111722
- - Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19
  - Serena Patel, Meenu Wadhwa
  - Vol 140 - Article 111785
- - CRISPR is a useful biological tool for detecting nucleic acid of SARS-CoV-2 in human clinical samples
  - Md. Rashidur Rahman, Md. Amjad Hossain, Md. Mozibullah, Fateh Al Mujib, Afrina Afrose, Md. Shahed-Al-Mahmud, Md. Aminul Islam Apu
  - Vol 140 - Article 111772
- - Theobroma cacao L. compounds: Theoretical study and molecular modeling as inhibitors of main SARS-CoV-2 protease
  - Osvaldo Yañez, Manuel Isaías Osorio, Carlos Areche, Alejandro Vasquez-Espinal, Jessica Bravo, Angélica Sandoval-Aldana, José M. Pérez-Donoso, Fernando González-Nilo, Maria João Matos, Edison Osorio, Olimpo García-Beltrán, William Tiznado
  - Vol 140 - Article 111764
- - Main protease inhibitors and drug surface hotspots for the treatment of COVID-19: A drug repurposing and molecular docking approach
  - Mahmudul Hasan, Md. Sorwer Alam Parvez, Kazi Faizul Azim, Md. Abdus Shukur Imran, Topu Raihan, Airin Gulshan, Samuel Muhit, Rubaiat Nazneen Akhand, Syed Sayeem Uddin Ahmed, Md Bashir Uddin
  - Vol 140 - Article 111742
- - COVID-19 and metabolic comorbidities: An update on emerging evidences for optimal therapies
  - Shuang Hua, Yong Yang, Danqi Zou, Jufei Li, Kaixuan Yan, Ying Xu, Xue Jiang, Xianglu Rong, Dewei Ye
  - Vol 140 - Article 111685
- - Disease-drug and drug-drug interaction in COVID-19: Risk and assessment
  - Devendra Kumar, Neerja Trivedi
  - Vol 139 - Article 111642
- - Novel and emerging mutations of SARS-CoV-2: Biomedical implications
  - Elmira Mohammadi, Fatemeh Shafiee, Kiana Shahzamani, Mohammad Mehdi Ranjbar, Abbas Alibakhshi, Shahrzad Ahangarzadeh, Leila Beikmohammadi, Laleh Shariati, Soodeh Hooshmandi, Behrooz Ataei, Shaghayegh Haghjooy Javanmard
  - Vol 139 - Article 111599
- - Babaodan controls excessive immune responses and may represent a cytokine-targeted agent suitable for COVID-19 treatment
  - Jing Qian, Hangdi Xu, Dongqing Lv, Wei Liu, Enguo Chen, Yong Zhou, Yi Wang, Kejing Ying, Xiaohui Fan
  - Vol 139 - Article 111586
- - Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials?
  - Douglas Dourado, Danielle T. Freire, Daniel T. Pereira, Lucas Amaral-Machado, Éverton N. Alencar, André Luís Branco de Barros, E. Sócrates T. Egito
  - Vol 139 - Article 111578
- - Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach
  - Zahra Molavi, Sara Razi, Seyed Amir Mirmotalebisohi, Amirjafar Adibi, Marzieh Sameni, Farshid Karami, Vahid Niazi, Zahra Niknam, Morteza Aliashrafi, Mohammad Taheri, Soudeh Ghafouri-Fard, Shabnam Jeibouei, Soodeh Mahdian, Hakimeh Zali, Mohammad Mehdi Ranjbar, Mohsen Yazdani
  - Vol 138 - Article 111544
- - Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients: A randomized, controlled clinical trial
  - Marcelo Augusto Duarte Silveira, David De Jong, Andresa Aparecida Berretta, Erica Batista dos Santos Galvão, Juliana Caldas Ribeiro, Thiago Cerqueira-Silva, Thais Chaves Amorim, Luis Filipe Miranda Rebelo da Conceição, Marcel Miranda Dantas Gomes, Maurício Brito Teixeira, Sergio Pinto de Souza, Marcele Helena Celestino Alves dos Santos, Raissa Lanna Araújo San Martin, Márcio de Oliveira Silva, Monique Lírio, Lis Moreno, Julio Cezar Miranda Sampaio, Renata Mendonça, Silviana Salles Ultchak, Fabio Santos Amorim, João Gabriel Rosa Ramos, Paulo Benigno Pena Batista, Suzete Nascimento Farias da Guarda, Ana Verena Almeida Mendes, Rogerio da Hora Passos, for the BeeCovid Team
  - Vol 138 - Article 111526
- - Potential therapeutic agents to COVID-19: An update review on antiviral therapy, immunotherapy, and cell therapy
  - Mona Sadat Mirtaleb, Amir Hossein Mirtaleb, Hassan Nosrati, Jalal Heshmatnia, Reza Falak, Reza Zolfaghari Emameh
  - Vol 138 - Article 111518
- - Impact of renin-angiotensin system inhibitors on mortality during the COVID Pandemic among STEMI patients undergoing mechanical reperfusion: Insight from an international STEMI registry
  - Giuseppe De Luca, Miha Cercek, Lisette Okkels Jensen, Oliver Bushljetikj, Lucian Calmac, Tom Johnson, Montserrat Gracida Blancas, Vladimir Ganyukov, Wojtek Wojakowski, Clemens von Birgelen, Alexander IJsselmuiden, Bernardo Tuccillo, Francesco Versaci, Jurrien Ten Berg, Mika Laine, Tim Berkout, Gianni Casella, Petr Kala, Bernabé López Ledesma, Victor Becerra, Roberto Padalino, Andrea Santucci, Xavier Carrillo, Alessandra Scoccia, Giovanni Amoroso, Arpad Lux, Tomas Kovarnik, Periklis Davlouros, Gabriele Gabrielli, Xacobe Flores Rios, Nikola Bakraceski, Sébastien Levesque, Vincenzo Guiducci, Michał Kidawa, Lucia Marinucci, Filippo Zilio, Gennaro Galasso, Enrico Fabris, Maurizio Menichelli, Stephane Manzo, Gianluca Caiazzo, Jose Moreu, Juan Sanchis Forés, Luca Donazzan, Luigi Vignali, Rui Teles, Pierfrancesco Agostoni, Francisco Bosa Ojeda, Heidi Lehtola, Santiago Camacho-Freiere, Adriaan Kraaijeveld, Ylitalo Antti, Gabriella Visconti, Iñigo Lozano Martínez-Luengas, Bruno Scheller, Dimitrios Alexopulos, Raul Moreno, Elvin Kedhi, Giuseppe Uccello, Benjamin Faurie, Alejandro Gutierrez Barrios, Fortunato Scotto Di Uccio, Bor Wilbert, Giuliana Cortese, Maurits T. Dirksen, Guido Parodi, Monica Verdoia
  - Vol 138 - Article 111469
- - Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2
  - Kenneth S. Plante, Varun Dwivedi, Jessica A. Plante, Diana Fernandez, Divya Mirchandani, Nathen Bopp, Patricia V. Aguilar, Jun-Gyu Park, Paula Pino Tamayo, Jennifer Delgado, Vinay Shivanna, Jordi B. Torrelles, Luis Martinez-Sobrido, Rick Matos, Scott C. Weaver, K. Jagannadha Sastry, Robert A. Newman
  - Vol 138 - Article 111457
- - Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection
  - Justin Fortune Creeden, Ali Sajid Imami, Hunter M. Eby, Cassidy Gillman, Kathryn N. Becker, Jim Reigle, Elissar Andari, Zhixing K. Pan, Sinead M. O’Donovan, Robert E. McCullumsmith, Cheryl B. McCullumsmith
  - Vol 138 - Article 111437
- - Flavonoids against the SARS-CoV-2 induced inflammatory storm
  - Alena Liskova, Marek Samec, Lenka Koklesova, Samson M. Samuel, Kevin Zhai, Raghad Khalid Al-Ishaq, Mariam Abotaleb, Vladimir Nosal, Karol Kajo, Milad Ashrafizadeh, Ali Zarrabi, Aranka Brockmueller, Mehdi Shakibaei, Peter Sabaka, Ioana Mozos, David Ullrich, Robert Prosecky, Giampiero La Rocca, Martin Caprnda, Dietrich Büsselberg, Luis Rodrigo, Peter Kruzliak, Peter Kubatka
  - Vol 138 - Article 111430
- - Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review
  - Saniya Mahendiratta, Seema Bansal, Phulen Sarma, Harish Kumar, Gajendra Choudhary, Subodh Kumar, Ajay Prakash, Rakesh Sehgal, Bikash Medhi
  - Vol 137 - Article 111300
- - The direct evidence and mechanism of traditional Chinese medicine treatment of COVID-19
  - Xuedong An, YueHong Zhang, Liyun Duan, De Jin, Shenghui Zhao, RongRong Zhou, Yingying Duan, Fengmei Lian, Xiaolin Tong
  - Vol 137 - Article 111267
- - Targets and strategies for vaccine development against SARS-CoV-2
  - Jonaid Ahmad Malik, Almas Hanif Mulla, Tahmeena Farooqi, Faheem Hyder Pottoo, Sirajudheen Anwar, Kannan R.R. Rengasamy
  - Vol 137 - Article 111254
- - Human endeavor for anti-SARS-CoV-2 pharmacotherapy: A major strategy to fight the pandemic
  - Ruixuan Wang, Preyesh Stephen, Yi Tao, Wenfa Zhang, Sheng-Xiang Lin
  - Vol 137 - Article 111232
- - Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection
  - Sheila Maestro, Karol M. Córdoba, Cristina Olague, Josepmaria Argemi, Matías A. Ávila, Gloria González-Aseguinolaza, Cristian Smerdou, Antonio Fontanellas
  - Vol 137 - Article 111384
- - Induced dysregulation of ACE2 by SARS-CoV-2 plays a key role in COVID-19 severity
  - Maryam Eskandari Mehrabadi, Roohullah Hemmati, Amin Tashakor, Ahmad Homaei, Masoumeh Yousefzadeh, Karim Hemati, Saman Hosseinkhani
  - Vol 137 - Article 111363
- - Repurposing potential of Ayurvedic medicinal plants derived active principles against SARS-CoV-2 associated target proteins revealed by molecular docking, molecular dynamics and MM-PBSA studies
  - Akalesh Kumar Verma, Vikas Kumar, Sweta Singh, Bhabesh Ch. Goswami, Ihosvany Camps, Aishwarya Sekar, Sanghwa Yoon, Keun Woo Lee
  - Vol 137 - Article 111356
- - SARS-CoV-2: From the pathogenesis to potential anti-viral treatments
  - Peyman Kheirandish Zarandi, Mohammad Reza Zinatizadeh, Maryam Zinatizadeh, Mohammad Hadi Yousefi, Nima Rezaei
  - Vol 137 - Article 111352
- - Effective drugs used to combat SARS-CoV-2 infection and the current status of vaccines
  - Annoor Awadasseid, Yanling Wu, Yoshimasa Tanaka, Wen Zhang
  - Vol 137 - Article 111330
- - An update review of emerging small-molecule therapeutic options for COVID-19
  - Dengke Tian, Yuzhi Liu, Chengyuan Liang, Liang Xin, Xiaolin Xie, Dezhu Zhang, Minge Wan, Han Li, Xueqi Fu, Hong Liu, Wenqiang Cao
  - Vol 137 - Article 111313
- - Research progress of traditional Chinese medicine against COVID-19
  - Wei Ren, Pan Liang, Yue Ma, Qin Sun, Qingrong Pu, Li Dong, Gang Luo, Maryam Mazhar, Jiali Liu, Raoqiong Wang, Sijin Yang
  - Vol 137 - Article 111310
- - COVID-19 and inflammatory bowel disease: A pathophysiological assessment
  - Chunxiu Yang, Shu-Yuan Xiao
  - Vol 135 - Article 111233
- - The neuropsychiatric manifestations of COVID-19: Interactions with psychiatric illness and pharmacological treatment
  - Esmé Jansen van Vuren, Stephan F. Steyn, Christiaan B. Brink, Marisa Möller, Francois P. Viljoen, Brian H. Harvey
  - Vol 135 - Article 111200
- - 4-Aminoquinoline compounds from the Spanish flu to COVID-19
  - Roberto Barbosa Bazotte, Sandro Massao Hirabara, Tamires Afonso Duarte Serdan, Raquel Bragante Gritte, Talita Souza-Siqueira, Renata Gorjao, Laureane Nunes Masi, Marina Masetto Antunes, Vinicius Cruzat, Tania Cristina Pithon-Curi, Rui Curi
  - Vol 135 - Article 111138
- - Impact of virus genetic variability and host immunity for the success of COVID-19 vaccines
  - Wagner Gouvêa dos Santos
  - Vol 136 - Article 111272
- - The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators
  - Hosam M. Habib, Sahar Ibrahim, Aamnah Zaim, Wissam H. Ibrahim
  - Vol 136 - Article 111228
- - Multifunctional angiotensin converting enzyme 2, the SARS-CoV-2 entry receptor, and critical appraisal of its role in acute lung injury
  - Murat Oz, Dietrich Ernst Lorke
  - Vol 136 - Article 111193
- - Could natural products modulate early inflammatory responses, preventing acute respiratory distress syndrome in COVID-19-confirmed patients?
  - Lucas Amaral-Machado, Wógenes N. Oliveira, Victor M. Rodrigues, Nathan A. Albuquerque, Éverton N. Alencar, Eryvaldo S.T. Egito
  - Vol 134 - Article 111143
- - Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver
  - Han-Yu Lei, Ying-He Ding, Kai Nie, Yin-Miao Dong, Jia-Hao Xu, Meng-Ling Yang, Meng-Qi Liu, Le Wei, MI Nasser, Lin-Yong Xu, Ping Zhu, Ming-Yi Zhao
  - Vol 133 - Article 111064
- - A traditional Chinese medicine formula NRICM101 to target COVID-19 through multiple pathways: A bedside-to-bench study
  - Keng-Chang Tsai, Yi-Chia Huang, Chia-Ching Liaw, Chia-I Tsai, Chun-Tang Chiou, Chien-Jung Lin, Wen-Chi Wei, Sunny Jui-Shan Lin, Yu-Hwei Tseng, Kuo-Ming Yeh, Yi-Ling Lin, Jia-Tsrong Jan, Jian-Jong Liang, Chun-Che Liao, Wen-Fei Chiou, Yao-Haur Kuo, Shen-Ming Lee, Ming-Yung Lee, Yi-Chang Su
  - Vol 133 - Article 111037
- - Potential molecular targets of nonstructural proteins for the development of antiviral drugs against SARS-CoV-2 infection
  - Xiao-huan Liu, Xiao Zhang, Zhen-hua Lu, You-shuang Zhu, Tao Wang
  - Vol 133 - Article 111035
- - Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine
  - Bianza Moise Bakadia, Feng He, Tiatou Souho, Lallepak Lamboni, Muhammad Wajid Ullah, Biaou Ode Boni, Abeer Ahmed Qaed Ahmed, Biampata Mutu Mukole, Guang Yang
  - Vol 133 - Article 111008
- - Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes
  - Mina T. Kelleni
  - Vol 133 - Article 110982
- - SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role
  - Ahmad Ud Din, Maryam Mazhar, Muhammed Waseem, Waqar Ahmad, Asma Bibi, Adil Hassan, Niaz Ali, Wang Gang, Gao Qian, Razi Ullah, Tariq Shah, Mehraj Ullah, Israr Khan, Muhammad Farrukh Nisar, Jianbo Wu
  - Vol 133 - Article 110947
- - Decoding the silent walk of COVID-19: Halting its spread using old bullets
  - Mukesh Kumar, Jitender Madan, Rupinder Kaur Sodhi, Shashi Bala Singh, Anju Katyal
  - Vol 133 - Article 110891
- - Tocilizumab combined with favipiravir in the treatment of COVID-19: A multicenter trial in a small sample size
  - Hong Zhao, Qi Zhu, Chi Zhang, Jiawen Li, Ming Wei, Yuhong Qin, Guilin Chen, Ke Wang, Junhua Yu, Zhao Wu, Xianxiang Chen, Guiqiang Wang
  - Vol 133 - Article 110825
- - Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19
  - Jayanta Talukdar, Bhaskar Bhadra, Tomal Dattaroy, Vinod Nagle, Santanu Dasgupta
  - Vol 132 - Article 110886
- - Innate and adaptive immune responses against coronavirus
  - Arezoo Hosseini, Vida Hashemi, Navid Shomali, Faezeh Asghari, Tohid Gharibi, Morteza Akbari, Saber Gholizadeh, Abbas Jafari
  - Vol 132 - Article 110859
- - From the perspective of Traditional Chinese Medicine: Treatment of mental disorders in COVID-19 survivors
  - Ke Ma, Xin Wang, Shiyao Feng, Xueshan Xia, Hongxiu Zhang, Abdul Rahaman, Zhenfei Dong, Yanting Lu, Xiuyang Li, Xiaoyu Zhou, Haijun Zhao, Yuan Wang, Shijun Wang, Zulqarnain Baloch
  - Vol 132 - Article 110810
- - Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects
  - Desmond Omane Acheampong, Isaac Kyei Barffour, Alex Boye, Enoch Aninagyei, Stephen Ocansey, Martin Tangnaa Morna
  - Vol 131 - Article 110748
- - CRISPR/Cas13: A potential therapeutic option of COVID-19
  - Melika Lotfi, Nima Rezaei
  - Vol 131 - Article 110738
- - The role of Interleukin 6 inhibitors in therapy of severe COVID-19
  - E. Nasonov, M. Samsonov
  - Vol 131 - Article 110698
- - Can a metabolism-targeted therapeutic intervention successfully subjugate SARS-COV-2? A scientific rational
  - Kamran Mansouri, Mohsen Rastegari-Pouyani, Maryam Ghanbri-Movahed, Mehrnoush Safarzadeh, Sara Kiani, Zahra Ghanbari-Movahed
  - Vol 131 - Article 110694
- - ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19
  - Mengzhen Dong, Jie Zhang, Xuefeng Ma, Jie Tan, Lizhen Chen, Shousheng Liu, Yongning Xin, Likun Zhuang
  - Vol 131 - Article 110678
- - Insights into antiviral mechanisms of remdesivir, lopinavir/ritonavir and chloroquine/hydroxychloroquine affecting the new SARS-CoV-2
  - Katya Uzunova, Elena Filipova, Velichka Pavlova, Toni Vekov
  - Vol 131 - Article 110668
- - Candesartan could ameliorate the COVID-19 cytokine storm
  - Abdel G. Elkahloun, Juan M. Saavedra
  - Vol 131 - Article 110653
- - Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease : Running title: Propolis against SARS-CoV-2 infection and COVID-19
  - Andresa Aparecida Berretta, Marcelo Augusto Duarte Silveira, José Manuel Cóndor Capcha, David De Jong
  - Vol 131 - Article 110622
- - Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects
  - Liu-Cheng Li, Zhi-Hui Zhang, Wen-Cheng Zhou, Jie Chen, Hua-Qian Jin, Hong-Mei Fang, Qin Chen, Ye-Cheng Jin, Jiao Qu, Lian-Di Kan
  - Vol 130 - Article 110641
- - SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia
  - Wei Chen, Jie Zhang, Xijian Qin, Weixiao Wang, Miaomiao Xu, Lin-Fa Wang, Chuanjun Xu, Shuangshuang Tang, Pei Liu, Libo Zhang, Xuan Liu, Yongchen Zhang, Changhua Yi, Zhiliang Hu, Yongxiang Yi
  - Vol 130 - Article 110629
- - Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19
  - Ulf Norinder, Astrud Tuck, Kalle Norgren, Vesna Munic Kos
  - Vol 130 - Article 110582
- - PARP-inhibitors in a non‐oncological indication as COVID-19: Are we aware about its potential role as anti-thrombotic drugs? The discussion is open
  - Ettore Capoluongo
  - Vol 130 - Article 110536
- - Clinical efficacy of glucocorticoid on the treatment of patients with COVID-19 pneumonia: A single-center experience
  - Yan Hu, Tingping Wang, Zhimin Hu, Xuan Wang, Zhengbin Zhang, Li Li, Peng Peng
  - Vol 130 - Article 110529
- - Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment
  - Siyi Xin, Xueqi Cheng, Bo Zhu, Xiaolong Liao, Feng Yang, Lina Song, Yan Shi, Xuefeng Guan, Renyi Su, Jian Wang, Limin Xing, Xiping Xu, Lin Jin, Yanping Liu, Wei Zhou, Dongwei Zhang, Liang Liang, You Yu, Rui Yu
  - Vol 129 - Article 110500
- - Outbreak of COVID-19: An emerging global pandemic threat
  - Minhua Peng
  - Vol 129 - Article 110499
- - Natural history of COVID-19 and current knowledge on treatment therapeutic options
  - Wagner Gouvea dos Santos
  - Vol 129 - Article 110493
- - When science goes viral: The research response during three months of the COVID-19 outbreak
  - Joanna Nowakowska, Joanna Soboci?ska, Mateusz Lewicki, ?aneta Lema?ska, Piotr Rzymski
  - Vol 129 - Article 110451
- - Strategies and perspectives to develop SARS-CoV-2 detection methods and diagnostics
  - Rekha Jalandra, Amit K. Yadav, Damini Verma, Nishu Dalal, Minakshi Sharma, Rajeev Singh, Anil Kumar, Pratima R. Solanki
  - Vol 129 - Article 110446
- - Yidu-toxicity blocking lung decoction ameliorates inflammation in severe pneumonia of SARS-COV-2 patients with Yidu-toxicity blocking lung syndrome by eliminating IL-6 and TNF-a
  - Jie Zhao, Xiaodong Yang, Chenghua Wang, Shuai Song, Kun Cao, Taohua Wei, Qiaoxue Ji, Wanqun Zheng, Jiali Li, Xue Zhou, Jie Liu
  - Vol 129 - Article 110436
- - Monoclonal antibody as a potential anti-COVID-19
  - Leila Jahanshahlu, Nima Rezaei
  - Vol 129 - Article 110337
- - Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming
  - Jian Chen, Yong-kui Wang, Yuan Gao, Ling-San Hu, Jiang-wei Yang, Jian-ru Wang, Wen-jie Sun, Zhi-qiang Liang, Ye-min Cao, Yong-bing Cao
  - Vol 129 - Article 110281
- - Analysis of the molecular mechanism of Pudilan (PDL) treatment for COVID-19 by network pharmacology tools
  - Qi Kong, Yue Wu, Yu Gu, Qi Lv, Feifei Qi, Shuran Gong, Xiuping Chen
  - Vol 128 - Article 110316
- - Emerging pharmacotherapies for COVID-19
  - Rachana Salvi, Panini Patankar
  - Vol 128 - Article 110267
- - New understanding of the damage of SARS-CoV-2 infection outside the respiratory system
  - Yuhao Zhang, Xiuchao Geng, Yanli Tan, Qiang Li, Can Xu, Jianglong Xu, Liangchao Hao, Zhaomu Zeng, Xianpu Luo, Fulin Liu, Hong Wang
  - Vol 127 - Article 110195
- - Occupational exposure to SARS-CoV-2 in burns treatment during the COVID-19 epidemic: Specific diagnosis and treatment protocol
  - Zhifeng Huang, Donglin Zhuang, Bing Xiong, David Xingfei Deng, Hanhua Li, Wen Lai
  - Vol 127 - Article 110176
- - Advances in the relationship between coronavirus infection and cardiovascular diseases
  - Mengmeng Zhao, Menglong Wang, Jishou Zhang, Jing Ye, Yao Xu, Zhen Wang, Di Ye, Jianfang Liu, Jun Wan
  - Vol 127 - Article 110230
- - The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: Inhibition of dendritic cell functions via Toll like receptor 9 signaling
  - Jiaochan Han, Xing Li, Xiaoqing Luo, Juan He, Xuechan Huang, Qingyou Zhou, Yanping Han, Hongyu Jie, Jian Zhuang, Yehao Li, Fangyuan Yang, Zeqing Zhai, Shufan Wu, Yi He, Bin Yang, Erwei Sun
  - Vol 132 - Article 110848
- - Hydroxychloroquine potentiates the anti-cancer effect of bevacizumab on glioblastoma via the inhibition of autophagy
  - Lin-qing Liu, Shi-bing Wang, Yan-fei Shao, Jia-na Shi, Wei Wang, Wan-yuan Chen, Zi-qi Ye, Jin-ying Jiang, Qing-xia Fang, Guo-bing Zhang, Zi-xue Xuan
  - Vol 118 - Article 109339
- - Immunomodulatory effects of hydroxychloroquine on Th1/Th2 balance in women with repeated implantation failure
  - H. Ghasemnejad-berenji, M. Ghaffari Novin, M. Hajshafiha, H. Nazarian, S.M. Hashemi, B. Ilkhanizadeh, T. Ghasemnejad, S. Sadeghpour, M. Ghasemnejad-berenji
  - Vol 107 - p. 1277-1285
- - Novel function of hydroxychloroquine: Down regulation of T follicular helper cells in collagen-induced arthritis
  - Jiaochan Han, Qingyou Zhou, Xing Li, Juan He, Yanping Han, Hongyu Jie, Yi He, Erwei Sun
  - Vol 97 - p. 838-843
- - Induction of cytosine arabinoside-resistant human myeloid leukemia cell death through autophagy regulation by hydroxychloroquine
  - Yundeok Kim, Ju-In Eom, Hoi-Kyung Jeung, Ji Eun Jang, Jin Seok Kim, June-Won Cheong, Young Sam Kim, Yoo Hong Min
  - Vol 73 - p. 87-96
- - Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer
  - Pei-Du Jiang, Ying-Lan Zhao, Xiao-Qiang Deng, Yong-Qiu Mao, Wei Shi, Qing-Qing Tang, Zheng-Guang Li, Yu-Zhu Zheng, Sheng-Yong Yang, Yu-Quan Wei
  - Vol 64 - n°9 - p. 609-614
- - Combination therapy of chloroquine and methimazole in Graves’ disease: A pilot randomized controlled trial
  - Akbar Soltani, Alireza Moayyeri, Fereidoun Azizi
  - Vol 61 - n°4 - p. 241-243
- Voir +
- Voir -